Amendment: SEC Form SC 13D/A filed by Organogenesis Holdings Inc.

Amendment: SEC Form SC 13D/A filed by Organogenesis Holdings Inc.

Recent Analyst Ratings for
$ORGO

$ORGO
Insider Purchases

$ORGO
Analyst Ratings

$ORGO
SEC Filings

$ORGO
Insider Trading

$ORGO
Press Releases

$ORGO
Leadership Updates

$ORGO
Large Ownership Changes

Chat with this insight

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Chief Admin. and Legal Officer Freedman Lori bought $725,290 worth of shares (252,264 units at $2.88), increasing direct ownership by 42% to 846,459 units (SEC Form 4)

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Lake Street initiated coverage on Organogenesis with a new price target

Cantor Fitzgerald initiated coverage on Organogenesis with a new price target

Morgan Stanley initiated coverage on Organogenesis with a new price target

SEC Form DEF 14A filed by Organogenesis Holdings Inc.

SEC Form 10-Q filed by Organogenesis Holdings Inc.

Organogenesis Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Admin. and Legal Officer Freedman Lori bought $725,290 worth of shares (252,264 units at $2.88), increasing direct ownership by 42% to 846,459 units (SEC Form 4)

Vice President, Strategy Cavorsi Robert covered exercise/tax liability with 271 shares, decreasing direct ownership by 0.14% to 189,525 units (SEC Form 4)

Director Driscoll Michael Joseph sold $127,535 worth of shares (25,000 units at $5.10), decreasing direct ownership by 13% to 166,879 units (SEC Form 4)

Fastest customizable press release news feed in the world

Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results

Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Live Leadership Updates

Organogenesis Expands Manufacturing Capacity to Support Future Growth

Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock

Bionomics Announces Key Leadership Updates to Drive U.S.-Focused Transformation and Next Stage of Strategic Growth

This live feed shows all institutional transactions in real time.

SEC Form SC 13D filed by Organogenesis Holdings Inc.

11/14/24 8:09:56 PM ET

$ORGO

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $ORGO alert in real time by email

SC 13D/A 1 d899462dsc13da.htm SC 13D/A SC 13D/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 7)*

Organogenesis Holdings Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

68621F102

(CUSIP Number)

Lori Freedman

Chief Administrative and Legal Officer

Organogenesis Holdings Inc.

85 Dan Road

Canton, MA 02021

Tel: (781) 575-0775

With a copy to:

William R. Kolb

Ryan M. Rourke Reed

Foley Hoag LLP

155 Seaport Boulevard

Boston, MA 02210

Tel: (617) 832-1000

Fax: (617) 832-7000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

November 12, 2024

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are sent.

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 68621F102		13D		Page 2 of 19 Pages


1.		Names of Reporting Persons. Alan A. Ades
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO, PF
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization United States


CUSIP No. 68621F102		13D		Page 3 of 19 Pages


1.		Names of Reporting Persons Albert Erani
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization United States


CUSIP No. 68621F102		13D		Page 4 of 19 Pages


1.		Names of Reporting Persons. Glenn H. Nussdorf
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization United States


CUSIP No. 68621F102		13D		Page 5 of 19 Pages


1.		Names of Reporting Persons. Dennis Erani
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO, PF
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization United States


CUSIP No. 68621F102		13D		Page 6 of 19 Pages


1.		Names of Reporting Persons. Starr Wisdom
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization United States


CUSIP No. 68621F102		13D		Page 7 of 19 Pages


1.		Names of Reporting Persons. Organo PFG LLC
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization United States


CUSIP No. 68621F102		13D		Page 8 of 19 Pages


1.		Names of Reporting Persons. Organo Investors LLC
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization United States


CUSIP No. 68621F102		13D		Page 9 of 19 Pages


1.		Names of Reporting Persons. Alan Ades 2014 GRAT
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization United States


CUSIP No. 68621F102		13D		Page 10 of 19 Pages


1.		Names of Reporting Persons. Albert Erani Family Trust dated 12/29/2012
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization United States


CUSIP No. 68621F102		13D		Page 11 of 19 Pages


1.		Names of Reporting Persons. Dennis Erani 2012 Issue Trust dated 12/20/12
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization United States


CUSIP No. 68621F102		13D		Page 12 of 19 Pages


1.		Names of Reporting Persons. GN 2016 Family Trust u/a/d August 12, 2016
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization United States


CUSIP No. 68621F102		13D		Page 13 of 19 Pages


1.		Names of Reporting Persons. GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization United States


CUSIP No. 68621F102		13D		Page 14 of 19 Pages


1.		Names of Reporting Persons. RED Holdings, LLC
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization United States


CUSIP No. 68621F102				Page 15 of 19 Pages

This Amendment No. 7 (this “Amendment No. 7”) amends and supplements the beneficial ownership statement on Schedule 13D originally filed on December 20, 2018, as amended by Amendment No. 1 to the statement on Schedule 13D filed on November 27, 2019, Amendment No. 2 to the statement on Schedule 13D filed on November 19, 2020, Amendment No. 3 to the statement on Schedule 13D filed on May 11, 2021, Amendment No. 4 to the statement on Schedule 13D filed on June 1, 2021, Amendment No. 5 to the statement on Schedule 13D filed on December 17, 2021 and Amendment No. 6 to the statement on Schedule 13D filed on December 30, 2021 (such Schedule 13D and amendments, the “Original Statement”), on behalf of Alan A. Ades, Albert Erani, Glenn H. Nussdorf, Dennis Erani, Starr Wisdom, Organo PFG LLC, Organo Investors LLC, Dennis Erani 2012 Issue Trust dated 12/20/12, Alan Ades 2014 GRAT, Albert Erani Family Trust dated 12/29/2012, GN 2016 Family Trust u/a/d August 12, 2016, GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 and RED Holdings, LLC (collectively, the “Group”). The Original Statement, as amended by this Amendment No. 7 (the “Statement”), relates to the shares of Class A common stock, par value $0.0001 per share (the “Shares”), of Organogenesis Holdings Inc., a Delaware corporation (the “Issuer”).

Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Original Statement. This Amendment No. 7 amends the Original Statement as specifically set forth herein. Except as set forth in this Amendment No. 7, all previous Items in the Original Statement remain unchanged.

Item 4. Purpose of the Transaction

Item 4 of this Schedule 13D is hereby supplemented to include the following information:

On November 12, 2024, certain of the Reporting Persons entered into Stock Repurchase Agreements with the Issuer, pursuant to which the Issuer agreed to purchase Shares held by the Reporting Person at a price of $3.1597 per share (the “Repurchase”), which represents the 10-day trailing volume weighted average price per Share as of market close on November 11, 2024, in the amounts set forth in the table below.


Reporting Person	Number of Shares Repurchased
Alan A. Ades		294,000
Albert Erani		224,668
Glenn H. Nussdorf		2,550,822
A. Ades GRAT		3,761,909
RED Holdings		590,332

Total		7,421,731


CUSIP No. 68621F102				Page 16 of 19 Pages

Item 5. Interest in Securities of the Issuer.

Paragraph (a) of Item 5 of the Original Statement is hereby amended and restated as follows:

“The percentages of beneficial ownership reported in this Item 5, and on each Reporting Person’s cover page to this Statement, are based on a total of 125,154,771 Shares, which reflects the number of Shares reported as outstanding on November 5, 2024 in the Quarterly Report on Form 10-Q filed by the Issuer on November 12, 2024, reduced by the number of Shares subject to the Repurchase. All of the Share numbers reported below, and on each Reporting Person’s cover page to this Statement, are as of November 14, 2024 and give effect to the Repurchase. The cover page to this Statement for each Reporting Person is incorporated by reference in its entirety into this Item 5.

(a) Alan A. Ades is the beneficial owner of a total of 22,319,837 Shares, representing approximately 17.8% of the outstanding Shares and consisting of (i) 8,112,498 Shares held by Alan Ades, (ii) 3,075,865 Shares held by the A. Ades GRAT, (iii) 8,279,490 Shares held by Organo PFG and (iv) 2,851,984 Shares held by Organo Investors.

Albert Erani is the beneficial owner of a total of 17,920,498 Shares, representing approximately 14.3% of the outstanding Shares and consisting of (i) 5,000 Shares held by Albert Erani, (ii) 6,784,024 Shares held by RED Holdings, (iii) 8,279,490 Shares held by Organo PFG and (iv) 2,851,984 Shares held by Organo Investors.

Dennis Erani is the beneficial owner of a total of 10,043,701 Shares, representing approximately 8.0% of the outstanding Shares and consisting of (i) 1,314,517 Shares held by Dennis Erani, (ii) 8,382,031 Shares held by the D. Erani Trust and (iii) 347,153 Shares held by the Purchasing Trust. Susan Erani, who is Dennis Erani’s spouse, and Mr. Nussdorf are co-trustees of the Purchasing Trust.

Glenn H. Nussdorf is the beneficial owner of a total of 12,412,841 Shares, representing approximately 9.9% of the outstanding Shares and consisting of (i) 232,841 Shares held by Mr. Nussdorf, (ii) 1,418,680 Shares held by the GN Trust and (iii) 10,761,320 Shares held by the GN GRAT.

Starr Wisdom is the beneficial owner of a total of 20,000 Shares, representing approximately 0.0% of the outstanding Shares. Ms. Wisdom holds all such Shares directly.

Organo PFG is the beneficial owner of a total of 8,279,490 Shares, representing approximately 6.6% of the outstanding Shares. Organo PFG holds all such Shares directly. Alan Ades and Albert Erani are the managing members of Organo PFG.

Organo Investors is the beneficial owner of a total of 2,851,984 Shares, representing approximately 2.3% of the outstanding Shares. Organo Investors holds all such Shares directly. Alan Ades and Albert Erani are the managers of Organo Investors.

The A. Ades GRAT is the beneficial owner of a total of 3,075,865 Shares, representing approximately 2.5% of the outstanding Shares. The A. Ades GRAT holds all such Shares directly. Alan Ades is trustee of the A. Ades GRAT.

The A. Erani Trust does not beneficially own any Shares. Starr Wisdom, John Wisdom and Jeffrey Baddish are co-trustees of the A. Erani Trust.

The D. Erani Trust is the beneficial owner of a total of 8,382,031 Shares, representing approximately 6.7% of the outstanding Shares. The D. Erani Trust holds all such Shares directly. Mr. Nussdorf, Susan Erani, who is Dennis Erani’s spouse, and David Peretz are co-trustees of the D. Erani Trust.


CUSIP No. 68621F102				Page 17 of 19 Pages

The GN Trust is the beneficial owner of a total of 1,418,680 Shares, representing approximately 1.1% of the outstanding Shares. The GN Trust holds all such Shares directly. Michael Katz is the trustee of the GN Trust.

The GN GRAT is the beneficial owner of a total of 10,761,320 Shares, representing approximately 8.6% of the outstanding Shares. The GN GRAT holds all such Shares directly. Mr. Nussdorf is trustee of the GN GRAT.

RED Holdings is the beneficial owner of 6,784,024 Shares, representing approximately 5.4% of the outstanding Shares. RED Holdings holds all such Shares directly. Albert Erani is the sole manager of RED Holdings and the 2021 RED Trust is the sole member of RED Holdings.

By virtue of the relationships described in this Statement, the Reporting Persons may be deemed to constitute a “group” within the meaning of Rule 13d-5 under the Act. The filing of this Statement shall not be construed as an admission that a Reporting Person beneficially owns those shares held by another member of such group for purposes of Section 13(d) of the Act or for any other purpose. In addition, each Reporting Person expressly disclaims beneficial ownership of any securities reported herein except to the extent such Reporting Person actually exercises voting or dispositive power with respect to such securities.”

Paragraph (c) of Item 5 of the Original Statement is hereby amended and restated as follows:

“ (c) Except for the Repurchase, none of the members of the Group has effected any transactions in Shares during the past 60 days.”

Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

Item 6 of the Original Statement is supplemented as follows:

“The information set forth in or incorporated by reference in Items 4 and 5 of this Statement is incorporated by reference in its entirety into this Item 6.”

Item 7. Material to be Filed as Exhibits.

Item 7 of the Original Statement is hereby supplemented as follows:


Exhibit No.		Exhibit

99.18		Stock Repurchase Agreement, dated November 12, 2024 by and between the Issuer and Alan A. Ades.

99.19		Stock Repurchase Agreement, dated November 12, 2024 by and between the Issuer and Albert Erani.

99.20		Stock Repurchase Agreement, dated November 12, 2024 by and between the Issuer and Glenn H. Nussdorf.

99.21		Stock Repurchase Agreement, dated November 12, 2024 by and between the Issuer and the Alan Ades 2014 GRAT.

99.22		Stock Repurchase Agreement, dated November 12, 2024 by and between the Issuer and RED Holdings, LLC.

[signature page follows]


CUSIP No. 68621F102				Page 18 of 19 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.


November 14, 2024

	ALAN A. ADES

	By:	/s/ William R. Kolb, Attorney-in-fact
	William R. Kolb, Attorney-in-fact

	ALBERT ERANI

	By:	/s/ William R. Kolb, Attorney-in-fact
	William R. Kolb, Attorney-in-fact

	DENNIS ERANI

	By:	/s/ William R. Kolb, Attorney-in-fact
	William R. Kolb, Attorney-in-fact

	GLENN H. NUSSDORF

	By:	/s/ William R. Kolb, Attorney-in-fact
	William R. Kolb, Attorney-in-fact

	STARR WISDOM

	By:	/s/ William R. Kolb, Attorney-in-fact
	William R. Kolb, Attorney-in-fact

	ORGANO PFG LLC

	By:	/s/ William R. Kolb, Attorney-in-fact
	William R. Kolb, Attorney-in-fact


CUSIP No. 68621F102				Page 19 of 19 Pages


						ORGANO INVESTORS LLC

						By:		/s/ William R. Kolb, Attorney-in-fact
						William R. Kolb, Attorney-in-fact

						ALAN ADES 2014 GRAT

						By:		/s/ William R. Kolb, Attorney-in-fact
						William R. Kolb, Attorney-in-fact

						ALBERT ERANI FAMILY TRUST DATED 12/29/2012

						By:		/s/ William R. Kolb, Attorney-in-fact
						William R. Kolb, Attorney-in-fact

						DENNIS ERANI 2012 ISSUE TRUST DATED 12/20/12

						By:		/s/ William R. Kolb, Attorney-in-fact
						William R. Kolb, Attorney-in-fact

						GN 2016 FAMILY TRUST U/A/D AUGUST 12, 2016

						By:		/s/ William R. Kolb, Attorney-in-fact
						William R. Kolb, Attorney-in-fact

						GN 2016 ORGANO 10-YEAR GRAT U/A/D SEPTEMBER 30, 2016

						By:		/s/ William R. Kolb, Attorney-in-fact
						William R. Kolb, Attorney-in-fact

						RED HOLDINGS, LLC

						By:		/s/ William R. Kolb, Attorney-in-fact
						William R. Kolb, Attorney-in-fact

Get the next $ORGO alert in real time by email

Date	Price Target	Rating	Analyst
6/28/2024	$5.00	Buy	Lake Street
2/7/2024	$5.00	Overweight	Cantor Fitzgerald
6/15/2023	$5.00	Equal-Weight	Morgan Stanley
5/24/2023	$10.00	Neutral → Buy	BTIG Research
11/10/2022		Buy → Neutral	BTIG Research
8/10/2022		Outperform → Perform	Oppenheimer
11/10/2021	$26.00 → $20.00	Outperform	SVB Leerink
8/10/2021	$24.00 → $25.00	Outperform	Credit Suisse

Number of

Shares Beneficially

Owned by

Each

Reporting

Person

With

Sole Voting Power

11,188,363 Shares

Shared Voting Power

11,131,474 Shares

Sole Dispositive Power

11,188,363 Shares

Shared Dispositive Power

11,131,474 Shares